| Revision as of 17:40, 5 January 2004 editElBenevolente (talk | contribs)1,884 editsm Added Symbyax info← Previous edit | Revision as of 06:37, 30 January 2004 edit undoElBenevolente (talk | contribs)1,884 editsm Added new FDA indicationNext edit → | ||
| Line 1: | Line 1: | ||
| '''Olanzapine''' ('''Zyprexa<sup>®</sup>''', '''Symbyax<sup>®</sup>''') is one of the ] ] ]s. Olanzapine has been ] approved for treatment of ] |
'''Olanzapine''' ('''Zyprexa<sup>®</sup>''', '''Symbyax<sup>®</sup>''') is one of the ] ] ]s. Olanzapine has been ] approved for the treatment of ], acute ] in ], and as maintenance treatment in ]. The ] ] ''Prozac Spotlight'' argues that a ] study demonstrated that the drug was ineffective in treatment of Parkinson's disease. | ||
| In December 2003 the ] approved '''Symbyax<sup>®</sup>''' to treat ] ]. '''Symbyax<sup>®</sup>''' is a combination of ] and ]. | In December 2003 the ] approved '''Symbyax<sup>®</sup>''' to treat ] ]. '''Symbyax<sup>®</sup>''' is a combination of ] and ]. | ||
Revision as of 06:37, 30 January 2004
Olanzapine (Zyprexa, Symbyax) is one of the atypical antipsychotic medications. Olanzapine has been FDA approved for the treatment of schizophrenia, acute mania in bipolar disorder, and as maintenance treatment in bipolar disorder. The anti-psychiatry website Prozac Spotlight argues that a 1999 study demonstrated that the drug was ineffective in treatment of Parkinson's disease.
In December 2003 the FDA approved Symbyax to treat bipolar depression. Symbyax is a combination of fluoxetine and olanzapine.
Side Effects
Common side effects include muscle-rigidity, muscle-stiffness, muscle-twitches, restlesness, sedation, and weight-gain. Olanzapine is reported to cause tardive dyskinesia and neurological malignant syndrome.
Olanzapine is manufactured by Eli Lilly (NYSE: LLY).